Two Cases of Atezolizumab-Induced Hypophysitis

Cancer immunotherapy has emerged as treatment of multiple advanced cancer types. Immune checkpoint inhibitors, namely anticytotoxic T-lymphocyte antigen-4 (CTLA-4), antiprogrammed cell death-1 (PD-1), and antiprogrammed cell death-1 ligand 1 (PD-L1) antibodies, have been used for treatment of variou...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endocr Soc
Autori principali: Kanie, Keitaro, Iguchi, Genzo, Bando, Hironori, Fujita, Yasunori, Odake, Yukiko, Yoshida, Kenichi, Matsumoto, Ryusaku, Fukuoka, Hidenori, Ogawa, Wataru, Takahashi, Yutaka
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrine Society 2017
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5774896/
https://ncbi.nlm.nih.gov/pubmed/29362727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2017-00414
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi